Federal Trade Commission v. Watson Pharmaceuticals, Inc.

ON REMAND FROM THE SUPREME COURT OF THE UNITED STATES

PER CURIAM:

The district court’s judgment, which was entered on April 21, 2010, is VACATED, and this case is REMANDED for further proceedings consistent with the Supreme Court’s opinion in F.T.C. v. Actavis, Inc., - U.S. -, 133 S.Ct. 2223, 186 L.Ed.2d 343 (2013).